Financial Markets
Unichem Labs gains on proposal to consolidate USA generics formulations business under one entity
Unichem Laboratories advanced 2.97% to Rs 663.90 after the company announced that its board will meet on Monday, 30 September 2024, to consider integration and consolidation of all USA generic formulations business under single entity.